Clinical Study Results
cover?
1. Study Name
Title of the Study: Long-term Follow-up of Adult Philadelphia Chromosome-
negative Acute Lymphoblastic Leukemia Relapsed
Refractory Patients Enrolled in Study 00103311
Protocol Number: 20180138
Date of This 17 November 2021
Summary:
What does this summary cover?
This summary shows the main results from one clinical study. The results are only
for this study. Other studies may find different results. Researchers and health
authorities look at the results of many studies to decide which medicines work best
and are safest for participants.
Amgen has committed to make research results available to the public. This
summary has been provided as part of that commitment and should not be used for
any other purpose. It should not be considered to make a claim for any product or to
guide treatment decisions.
Some information in this summary may be different from the approved labelling for
blinatumomab. Your healthcare professional should refer to the full prescribing
information for proper use of blinatumomab.
2. Who Sponsored This Study?
Amgen Inc.
One Amgen Center Drive
Thousand Oaks, CA 91320-1799 USA
1